Dr. Vibha Jawa is a Principal Scientist at Amgen in the Department of Clinical Immunology since Dec 2003. As a Principal Investigator and Clinical Immunology representative on several of Amgen's drug development teams, her group is responsible for developing bioanalytical methods and strategies for non-clinical, clinical and post-marketing studies and for in vitro characterization of protein therapeutics. Her current research interests include understanding the impact of immunogenicity on drug exposure. She is also leading a cross functional group within Amgen that evaluates immune responses due to particles in formulated biotherapeutics, identifying immune cell derived cytokine signatures as biomarkers for early drug development and efficacy and prediction of immunogenic epitopes using in silico and in vitro technologies
clinical immunology,formulated biothetaputics